Biochem/physiol Actions
PF-06737007 is pan tropomyosin-related kinase (Trk) inhibitor.
Legal Information
Sold for research purposes under agreement from Pfizer Inc.
Other Notes
This compound was developed by Pfizer for Kinase Phosphatase Biology research. To learn more about Sigma′s partnership with Pfizer and view other authentic, high-quality Pfizer compounds, visit sigma.com/bsm-pfizer.
Packaging
5, 25 mg in glass bottle
This product has met the following criteria to qualify for the following awards: